NCT05282459 2026-04-17Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 MutationStanford UniversityPhase 1/2 Completed17 enrolled 12 charts
NCT02287233 2022-08-29A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous LeukemiaAbbViePhase 1/2 Completed94 enrolled 37 charts
NCT01667133 2022-06-13A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)TakedaPhase 1/2 Completed35 enrolled 36 charts
NCT01602952 2018-08-29Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKIIl-Yang Pharm. Co., Ltd.Phase 1/2 Completed85 enrolled
NCT00034684 2015-06-17Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)Merck Sharp & Dohme LLCPhase 1/2 Completed132 enrolled
NCT00129168 2008-04-01Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)Kanisa PharmaceuticalsPhase 1/2 Completed100 enrolled
NCT00233909 2008-04-01A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid LeukemiaKanisa PharmaceuticalsPhase 1/2 Completed55 enrolled